Valuation: Bayer AG

Market Cap 45.25B 51.52B 42.08B 38.62B 72.56B 4,961B 73.67B 500B 195B 2,439B 193B 189B 8,434B P/E 2026 *
19.9x
P/E 2027 * 14.9x
Enterprise Value 77.09B 87.77B 71.69B 65.79B 124B 8,453B 126B 851B 333B 4,156B 330B 322B 14,368B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.58x
Free-Float
100%
Yield 2026 *
0.5%
Yield 2027 * 1.37%
1 day-0.30%
1 week-4.95%
Current month-4.85%
1 month+16.34%
3 months+19.64%
6 months+3.38%
Current year+24.45%
1 week 45.49
Extreme 45.49
48.28
1 month 45.41
Extreme 45.41
53.92
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Buy

Chairman

2,671 0.0003%
18/03/26 Buy

Chief Executive Officer

21,050 0.0021%
18/03/26 Buy

Director

1,900 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%-4.95%+58.15%-10.55% 51.52B
+0.86%+1.43%+48.50%+160.39% 1,067B
+1.59%+4.09%+55.34%+53.96% 635B
+0.95%+1.91%+35.91%+81.14% 458B
+1.60%+6.25%+33.95%+29.84% 347B
-0.60%+1.52%+35.68%+39.76% 295B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 216B
+1.22%+2.66%+21.87%+59.73% 203B
-1.18%-3.70%+14.23%+66.51% 161B
Average +0.30%+0.70%+29.15%+45.66% 369.45B
Weighted average by Cap. +0.53%+1.85%+36.12%+76.45%

Financials

2026 *2027 *
Net sales 45.6B 51.92B 42.41B 38.92B 73.12B 5,000B 74.25B 504B 197B 2,458B 195B 191B 8,500B 46.76B 53.24B 43.48B 39.9B 74.97B 5,127B 76.13B 516B 202B 2,520B 200B 196B 8,714B
Net income 2.13B 2.42B 1.98B 1.81B 3.41B 233B 3.46B 23.48B 9.17B 115B 9.09B 8.89B 396B 2.93B 3.34B 2.73B 2.5B 4.7B 322B 4.77B 32.39B 12.65B 158B 12.53B 12.26B 547B
Net Debt 31.84B 36.25B 29.61B 27.17B 51.06B 3,491B 51.84B 352B 137B 1,716B 136B 133B 5,935B 28.71B 32.69B 26.7B 24.5B 46.04B 3,148B 46.75B 317B 124B 1,548B 123B 120B 5,351B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
24/07/26 €46.06 -0.30% 1,486,549
23/07/26 €46.20 -1.64% 2,346,811
22/07/26 €46.97 -1.36% 1,856,037
21/07/26 €47.62 +0.66% 1,471,496
20/07/26 €47.31 -2.37% 1,487,548
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
46.06EUR
Average target price
54.92EUR
Spread / Average Target
+19.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock